Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Colorectal Neoplasms 8Breast Neoplasms 7Polycythemia Vera 5Venous Thromboembolism 3Melanoma 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Tobacco Use Disorder 2Thrombocythemia, Essential 2Smoking Cessation 2Rectal Neoplasms 2Prostatic Neoplasms 2Neoplastic Cells, Circulating 2Neoplasms 2Neoplasm Metastasis 2Myeloproliferative Disorders 2Multiple Myeloma 2Lung Neoplasms 2Barrett Esophagus 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Tuberous Sclerosis 1Thromboembolism 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Seizures 1Salivary Gland Neoplasms 1Recurrence 1Primary Myelofibrosis 1Precancerous Conditions 1

Interventions

Cisplatin 11Carboplatin 7Docetaxel 6pembrolizumab 5Magnetic Resonance Spectroscopy 5Gemcitabine 5Cetuximab 5Trastuzumab 4Specimen Handling 4Radiotherapy 4Paclitaxel 4Sorafenib 3Nivolumab 3N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 3Lapatinib 3Goserelin 3Doxorubicin 3Capecitabine 3Biopsy 3sacituzumab govitecan 2darolutamide 2bicalutamide 2Radiotherapy, Intensity-Modulated 2Platinum 2Oxaliplatin 2Leuprolide 2Irinotecan 2Ipilimumab 2Dasatinib 2Chemotherapy, Adjuvant 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Salivary Gland Neoplasms × Aspirin × Clear all
NCT00020189 2013-06-19

Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡